AS

Alim Shaikh

Active Director Director DIN 08731324
DIN 08731324 First appointment Mar 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2020
Shareholding value •••• Premium profile

About Alim Shaikh

Data last updated:

Alim Shaikh is a Director at Saho Pharma Private Limited (since 2020). The company operates in Chemicals. Saho Pharma Private Limited reported revenue of ₹4.8 Lakh (FY 2024).

DIN 08731324
Primary Designation Director
Industry Chemicals
First Appointment 30 Mar 2020
Oldest Company Age 6 yrs
Largest company Saho Pharma Private Limited · ₹4.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Saho Pharma Private Limited U24230MH2020PTC339162
Director30 Mar 20202020₹4.8 Lakh (FY 2024)Active

Board colleagues of Alim Shaikh

NameDINCompanyDesignation
Shaikh Hakim Sattar08731323Saho Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Saho Pharma Private Limited
Premium access

Shareholding and investment profile for Alim Shaikh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alim Shaikh

Alim Shaikh currently holds 1 directorship: Saho Pharma Private Limited (Director, since 30 Mar 2020, revenue ₹4.8 Lakh (FY 2024)).

Alim Shaikh was first appointed on 30 Mar 2020 as Director at Saho Pharma Private Limited.

The current boards of Alim Shaikh's companies include Shaikh Hakim Sattar (Saho Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available